Literature DB >> 7835055

Current status of calcium channel blockers.

W H Frishman1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7835055     DOI: 10.1016/0146-2806(94)90002-7

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


× No keyword cloud information.
  7 in total

1.  Safety of kidney biopsy in elderly: a prospective study.

Authors:  Harbir Singh Kohli; A Jairam; Ashok Bhat; Kamal Sud; Vivekanand Jha; Krishan Lal Gupta; Vinay Sakhuja
Journal:  Int Urol Nephrol       Date:  2006-12-02       Impact factor: 2.370

2.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

3.  Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment?

Authors:  J A Foley; R C Becker
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

4.  Surgical bleeding: unexpected effect of a calcium antagonist.

Authors:  L E Wagenknecht; C D Furberg; J W Hammon; C Legault; B T Troost
Journal:  BMJ       Date:  1995-03-25

Review 5.  Role of a third generation calcium antagonist in the management of hypertension.

Authors:  M Epstein
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Effect of verapamil on urinary stone-forming risk factors.

Authors:  Kemal Sarica; Sakip Erturhan; Bulent Altay
Journal:  Urol Res       Date:  2006-12-13

7.  The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy.

Authors:  Kemal Sarica; Yener Inal; Sakip Erturhan; Faruk Yağci
Journal:  Urol Res       Date:  2006-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.